Followers | 689 |
Posts | 143817 |
Boards Moderated | 35 |
Alias Born | 03/10/2004 |
Friday, July 10, 2020 4:03:11 PM
By: TheStreet | July 8, 2020
• Barclays analyst Gaurav Jain downgraded Altria to equal weight from overweight and trimmed his share-price target to $43 from $50.
Altria (MO) shares fell Wednesday after Barclays analyst Gaurav Jain downgraded the tobacco titan to equal weight from overweight and trimmed his share-price target to $43 from $50.
He cited the company’s 100% exposure to the U.S., where it’s losing market share. In a commentary reported by The Fly, Jain forecast U.S. cigarette sales would fall 3% this year and 4% after that.
In April, Altria reported stronger-than-expected first-quarter earnings amid demand for its smoking and smokeless products.
The Richmond, Va., company earned $1.55 billion, or $1.09 a share, vs. $1.12 billion, or 92 cents, in the year-earlier quarter. Analysts polled by FactSet expected earnings of 98 cents.
Revenue totaled $6.36 billion vs. $5.63 billion a year ago, above analysts’ consensus forecast of $4.3 billion.
Morningstar analyst Philip Gorham wrote in a commentary after the earnings report that Altria was undervalued.
“Underlying trends in the U.S. cigarette industry appear to be intact following Altria's first-quarter results, which included very strong shipment numbers, with comparability affected by a number of technical issues,” he said.
“Aside from adjusting for the timing of some of the company's shipments that were brought forward into the first quarter, we are making only modest tweaks to our estimates for the remainder of the year and our longer-term outlook is unchanged. We are reiterating our wide-moat rating and $54 fair-value estimate.”
Altria shares recently traded at $39.63, down 0.8%, They have dropped 19% over the past three months. And they were down 20% in 2020 through the close of trading on Tuesday.
Read Full Story »»»
DiscoverGold
Information posted to this board is not meant to suggest any specific action, but to point out the technical signs that can help our readers make their own specific decisions. Caveat emptor!
• DiscoverGold
Recent MO News
- Altria and NJOY Respond to ITC Initial Determination in Complaint Against NJOY • Business Wire • 08/27/2024 12:00:00 PM
- Cruise and Uber Join Forces for Robotaxis, Alibaba Shifts Primary Listing to Hong Kong, Altria Hikes Dividend 4.1% • IH Market News • 08/23/2024 12:20:26 PM
- Altria Increases Quarterly Dividend by 4.1% to $1.02 Per Share • Business Wire • 08/22/2024 05:15:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/31/2024 11:23:37 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2024 11:02:01 AM
- Altria Reports 2024 Second-Quarter and First-Half Results; Narrows 2024 Full-Year Earnings Guidance • Business Wire • 07/31/2024 11:00:00 AM
- US Index Futures Up Ahead of Fed Decision; Oil Prices Surge Amid Middle East Tensions • IH Market News • 07/31/2024 10:01:30 AM
- Altria to Host Webcast of 2024 Second-Quarter and First-Half Results • Business Wire • 07/17/2024 02:00:00 PM
- Altria Announces PMTA Submission for on! PLUS™ Nicotine Pouches • Business Wire • 06/26/2024 08:52:00 PM
- UPS Divests Coyote Logistics in $1.025 Billion Deal with RXO, Under Armour Agrees to $434 million Settlement, and More News • IH Market News • 06/24/2024 11:00:20 AM
- NJOY Receives First FDA Authorizations for Menthol E-Vapor Products • Business Wire • 06/21/2024 10:17:00 PM
- Form 11-K - Annual report of employee stock purchase, savings and similar plans • Edgar (US Regulatory) • 06/07/2024 04:58:50 PM
- Form 11-K - Annual report of employee stock purchase, savings and similar plans • Edgar (US Regulatory) • 06/07/2024 04:57:12 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 06/05/2024 05:23:49 PM
- NJOY Submits Premarket Tobacco Product Applications to the FDA for NJOY ACE 2.0 Featuring Bluetooth®-enabled Access Restriction Technology • Business Wire • 05/20/2024 08:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 06:47:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/20/2024 06:47:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/20/2024 06:47:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/20/2024 06:46:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/20/2024 06:46:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/20/2024 06:46:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/20/2024 06:46:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/20/2024 06:46:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/20/2024 06:45:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/20/2024 06:45:36 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM